| Data at t0 | Data at t1 | ||||
---|---|---|---|---|---|---|
Clinical evaluations | N (%) | N (%) | ||||
Asthma severity | Â | Â | Â | Â | Â | Â |
1 | 29 (55,8%) | 21 (40,4%) | ||||
2 | 15 (28,8%) | 18 (34,6%) | ||||
3 | 6 (11,5%) | 10 (19,2%) | ||||
4 | 2 (3,8%) | 3 (5,8%) | ||||
Under-control asthma | 39 (75%) | 32 (61,5%) | ||||
Quantitative measures | Mean (standard deviation) | 50th P | 25th P–75th P | Mean (Standard deviation) | 50th P | 25th P–75th P |
FVC | 105,66 (15,36) | 106,60 | 97,85–116,15 | 106,21 (12,91) | 107,15 | 99,15–113,60 |
FEV1 | 100,10 (18,47) | 101,90 | 94,00–112,45 | 100,95 (17,28) | 102,30 | 90,55–113,15 |
FEV1/FVC | 94,10 (12,16) | 97,55 | 88,40–102,75 | 94,11 (11,37) | 96,35 | 88,60–102,55 |
FEF25–75 | 94,98 (32,29) | 98,85 | 71,90–120,45 | 94,64 (34,58) | 97,40 | 68,50–125,10 |
PAQLQ total score | 6,09 (1,04) | 6,48 | 5,85–6,85 | 6,24 (0,88) | 6,41 | 5,85–6,91 |
PAQLQ-symptoms | 6,79 (1,33) | 7,26 | 5,98–7,81 | 6,98 (1,12) | 7,34 | 6,46–7,84 |
PAQLQ-activity limitation | 4,77 (1,02) | 4,88 | 4,16–5,68 | 4,87 (0,94) | 5,08 | 4,08–5,88 |
PAQLQ-emotional function | 5,75 (0,92) | 6,23 | 5,86–6,23 | 5,90 (0,78) | 6,23 | 5,86–6,23 |